These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 8913355
21. Potent antitumor activity of the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl)adenine in choriocarcinoma-bearing rats. Hatse S, Naesens L, Degrève B, Segers C, Vandeputte M, Waer M, De Clercq E, Balzarini J. Int J Cancer; 1998 May 18; 76(4):595-600. PubMed ID: 9590139 [Abstract] [Full Text] [Related]
22. cycloSal-PMEA and cycloAmb-PMEA: potentially new phosphonate prodrugs based on the cycloSal-pronucleotide approach. Meier C, Görbig U, Müller C, Balzarini J. J Med Chem; 2005 Dec 15; 48(25):8079-86. PubMed ID: 16335932 [Abstract] [Full Text] [Related]
23. Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571. Koyama N, Koschmieder S, Tyagi S, Portero-Robles I, Chromic J, Myloch S, Nürnberger H, Rossmanith T, Hofmann WK, Hoelzer D, Ottmann OG. Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2025-31. PubMed ID: 16609011 [Abstract] [Full Text] [Related]
24. Metabolism and in vitro antiretroviral activities of bis(pivaloyloxymethyl) prodrugs of acyclic nucleoside phosphonates. Srinivas RV, Robbins BL, Connelly MC, Gong YF, Bischofberger N, Fridland A. Antimicrob Agents Chemother; 1993 Oct 01; 37(10):2247-50. PubMed ID: 8257154 [Abstract] [Full Text] [Related]
25. Cytostatic effect of 9-(2-phosphonomethoxyethyl) adenine (PMEA). II. Lymphoblastic leukemia in Sprague-Dawley rats. Otová B, Sladká M, Blazek K, Schramlová J, Votruba I, Holý A. Folia Biol (Praha); 1993 Oct 01; 39(3):142-9. PubMed ID: 8157135 [Abstract] [Full Text] [Related]
26. Carrier-mediated delivery improves the efficacy of 9-(2-phosphonylmethoxyethyl)adenine against hepatitis B virus. Bijsterbosch MK, Ying C, de Vrueh RL, de Clercq E, Biessen EA, Neyts J, van Berkel TJ. Mol Pharmacol; 2001 Sep 01; 60(3):521-7. PubMed ID: 11502883 [Abstract] [Full Text] [Related]
27. Treatment of visna virus infection in lambs with the acyclic nucleoside phosphonate analogue 9-(2-phosphonylmethoxyethyl)adenine (PMEA). Thormar H, Georgsson G, Gunnarsson E, Naesens L, Torsteinsdóttir S, Balzarini J, De Clercq E. Antivir Chem Chemother; 1998 May 01; 9(3):245-52. PubMed ID: 9875403 [Abstract] [Full Text] [Related]
28. The unsaturated acyclic nucleoside analogues bearing a sterically constrained (Z)-4'-benzamido-2'-butenyl moiety: Synthesis, X-ray crystal structure study, cytostatic and antiviral activity evaluations. Benci K, Wittine K, Radan M, Cetina M, Sedić M, Kraljević Pavelić S, Pavelić K, Clercq ED, Mintas M. Bioorg Med Chem; 2010 Sep 01; 18(17):6249-57. PubMed ID: 20696582 [Abstract] [Full Text] [Related]
29. A multifunctional 5-aminolevulinic acid derivative induces erythroid differentiation of K562 human erythroleukemic cells. Berkovitch-Luria G, Yakobovitch S, Weitman M, Nudelman A, Rozic G, Rephaeli A, Malik Z. Eur J Pharm Sci; 2012 Aug 30; 47(1):206-14. PubMed ID: 22705251 [Abstract] [Full Text] [Related]
30. Characterization of a multidrug resistant human erythroleukemia cell line (K562) exhibiting spontaneous resistance to 1-beta-D-arabinofuranosylcytosine. Grant S, Turner A, Nelms P, Yanovich S. Leukemia; 1995 May 30; 9(5):808-14. PubMed ID: 7769843 [Abstract] [Full Text] [Related]
32. Hydroxyurea induces a senescence-like change of K562 human erythroleukemia cell. Park JI, Jeong JS, Han JY, Kim DI, Gao YH, Park SC, Rodgers GP, Kim IH. J Cancer Res Clin Oncol; 2000 Aug 30; 126(8):455-60. PubMed ID: 10961388 [Abstract] [Full Text] [Related]
33. Multiple differentiation programs in K562 erythroleukemia cells and their regulation. Horton MA, Cedar SH, Maryanka D, Mills FC, Turberville C. Prog Clin Biol Res; 1983 Aug 30; 134():305-22. PubMed ID: 6582521 [Abstract] [Full Text] [Related]
34. Ureido derivatives of pyridine: a new class of inducers of murine erythroleukemia cell differentiation. Pappas IS, Niopas I, Tsiftsoglou AS. Anticancer Drug Des; 1992 Apr 30; 7(2):153-61. PubMed ID: 1575888 [Abstract] [Full Text] [Related]
35. 9-(2-phosphonylmethoxyethyl) derivatives of purine nucleotide analogs: A comparison of their metabolism and interaction with cellular DNA synthesis. Kramata P, Downey KM. Mol Pharmacol; 1999 Dec 30; 56(6):1262-70. PubMed ID: 10570054 [Abstract] [Full Text] [Related]
36. Intracellular metabolism and action of acyclic nucleoside phosphonates on DNA replication. Pisarev VM, Lee SH, Connelly MC, Fridland A. Mol Pharmacol; 1997 Jul 30; 52(1):63-8. PubMed ID: 9224813 [Abstract] [Full Text] [Related]
37. Pharmacokinetics in mice of the anti-retrovirus agent 9-(2-phosphonylmethoxyethyl)adenine. Naesens L, Balzarini J, De Clercq E. Drug Metab Dispos; 1992 Jul 30; 20(5):747-52. PubMed ID: 1358582 [Abstract] [Full Text] [Related]
38. α1-adrenergic drugs exhibit affinity to a thapsigargin-sensitive binding site and interfere with the intracellular Ca2+ homeostasis in human erythroleukemia cells. Fuchs R, Schraml E, Leitinger G, Letofsky-Papst I, Stelzer I, Haas HS, Schauenstein K, Sadjak A. Exp Cell Res; 2011 Dec 10; 317(20):2969-80. PubMed ID: 21851819 [Abstract] [Full Text] [Related]
39. Decursin and PDBu: two PKC activators distinctively acting in the megakaryocytic differentiation of K562 human erythroleukemia cells. Kim HH, Ahn KS, Han H, Choung SY, Choi SY, Kim IH. Leuk Res; 2005 Dec 10; 29(12):1407-13. PubMed ID: 15992925 [Abstract] [Full Text] [Related]
40. In vivo effects of antiviral acyclic nucleoside phosphonate 9-[2-(phosphonomethoxy)ethyl]adenine (adefovir) on cytochrome P450 system of rat liver microsomes. Zídek Z, Anzenbacher P, Anzenbacherová E, Buchar E, Kmonícková E, Potmesil P, Holý A. J Biomed Sci; 2006 May 10; 13(3):295-301. PubMed ID: 16416053 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]